M. Kabus

Clinical importance of prothrombotic risk factors in pediatric patients with malignancy – impact of central venous lines

R. Knöfler, E. Siegert, I. Lauterbach, 1999, European Journal of Pediatrics.

Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids.

M. Gahr, F. Pessler, G. Heubner, 2011, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Clinical experiences with low-molecular weight heparins in pediatric patients.

S. Hofmann, J. Wendisch, G. Siegert, 2001, Thrombosis research.

[Lethal meningeal encephalitis from Cryptococcus neoformans var. neoformans in a girl without serious immunodeficiency].

J. Wendisch, M. Kabus, R. Schwarze, 1996, Mycoses.

The genotype of the original Wiskott phenotype.

A. Meindl, V. Binder, B. Belohradsky, 2006, The New England journal of medicine.

Thrombolytic Therapy in Children- Clinical Experiences with Recombinant Tissue-Plasminogen Activator

R. Knöfler, I. Lauterbach, G. Weissbach, 2001, Seminars in thrombosis and hemostasis.

Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids.

M. Gahr, F. Pessler, G. Heubner, 2011, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.